Patents by Inventor Guriq Basi

Guriq Basi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized antibodies that recognize beta amyloid peptide
    Patent number: 9051363
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: June 9, 2015
    Assignees: JANSSEN SCIENCES IRELAND UC, WYETH LLC
    Inventors: Guriq Basi, Jose William Saldanha, Dale B. Schenk
  • Humanized A? antibodies for use in improving cognition
    Patent number: 8916165
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with beta amyloid (A?). Preferred agents include antibodies, e.g., humanized antibodies specific for A?.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: December 23, 2014
    Assignees: Janssen Alzheimer Immunotherapy, Wyeth LLC
    Inventors: Guriq Basi, Jack Steven Jacobsen
  • Humanized antibodies that recognize beta amyloid peptide
    Patent number: 8128928
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Grant
    Filed: August 13, 2007
    Date of Patent: March 6, 2012
    Assignees: Wyeth LLC, Janssen Alzheimer Immunotherapy
    Inventors: Guriq Basi, Jose Saldanha
  • Humanized antibodies that recognize beta amyloid peptide
    Publication number: 20110142823
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Application
    Filed: August 13, 2007
    Publication date: June 16, 2011
    Applicants: Janssen Alzheimer Immunotherapy, Wyeth
    Inventors: Guriq Basi, Jose Saldanha
  • Humanized antibodies that recognize beta amyloid peptide
    Patent number: 7871615
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include antibodies, e.g., humanized antibodies.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: January 18, 2011
    Assignees: Janssen Alzheimer Immunotherapy, Wyeth LLC
    Inventors: Guriq Basi, Jose Saldanha, Frédérique Bard
  • Humanized antibodies that recognize ?-amyloid peptide
    Patent number: 7700751
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: April 20, 2010
    Assignees: Janssen Alzheimer Immunotherapy, Wyeth
    Inventors: Guriq Basi, Jose William Saldanha, Dale B. Schenk
  • Humanized antibodies that recognize beta amyloid peptide
    Patent number: 7625560
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include antibodies, e.g., humanized antibodies.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: December 1, 2009
    Assignee: Janssen Alzheimer Immunotherapy
    Inventors: Guriq Basi, Jack Steven Jacobsen
  • Humanized antibodies that recognize beta amyloid peptide
    Patent number: 7582733
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: September 1, 2009
    Assignees: Elan Pharma International Limited, Wyeth
    Inventors: Guriq Basi, Jose William Saldanha
  • HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE
    Publication number: 20090069544
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Application
    Filed: August 20, 2007
    Publication date: March 12, 2009
    Inventors: Guriq Basi, Jose William Saldanha, Dale B. Schenk
  • HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE
    Publication number: 20080281082
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Application
    Filed: August 20, 2007
    Publication date: November 13, 2008
    Inventors: Guriq Basi, Jose William Saldanha, Dale B. Schenk
  • HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE
    Publication number: 20080221306
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Application
    Filed: August 20, 2007
    Publication date: September 11, 2008
    Inventors: Guriq Basi, Jose Saldanha, Dale Schenk
  • Humanized antibodies that recognize beta amyloid peptide
    Publication number: 20080050367
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Application
    Filed: September 5, 2006
    Publication date: February 28, 2008
    Inventors: Guriq Basi, Jose Saldanha, Dale Schenk
  • Humanized antibodies that recognize beta-amyloid peptide
    Publication number: 20070238154
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Application
    Filed: February 16, 2007
    Publication date: October 11, 2007
    Applicants: Elan Pharma International Limited, Wyeth
    Inventors: Guriq Basi, Jose Saldanha, Dale Schenk
  • Humanized antibodies that recognize beta amyloid peptide
    Patent number: 7256273
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Grant
    Filed: March 12, 2003
    Date of Patent: August 14, 2007
    Assignees: Elan Pharma International Limited, Wyeth
    Inventors: Guriq Basi, Jose Saldanha
  • Humanized antibodies that recognize beta amyloid peptide
    Patent number: 7189819
    Abstract: The invention provides improves agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: March 13, 2007
    Assignees: Wyeth, Neuralab Limited
    Inventors: Guriq Basi, Jose William Saldanha
  • Humanized antibodies that recognize beta amyloid peptide
    Patent number: 7179892
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Grant
    Filed: March 12, 2003
    Date of Patent: February 20, 2007
    Assignees: Neuralab Limited, Wyeth
    Inventors: Guriq Basi, Jose William Saldanha
  • Humanized antibodies that recognize beta amyloid peptide
    Publication number: 20060280743
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Application
    Filed: April 28, 2006
    Publication date: December 14, 2006
    Applicants: Neuralab Limited, Wyeth
    Inventors: Guriq Basi, Jose Saldanha
  • Humanized Abeta antibodies for use in improving cognition
    Publication number: 20060198851
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with beta amyloid (A?). Preferred agents include antibodies, e.g., humanized antibodies specific for A?.
    Type: Application
    Filed: December 15, 2005
    Publication date: September 7, 2006
    Inventors: Guriq Basi, Jack Jacobsen
  • Humanized antibodies that recognize beta amyloid peptide
    Publication number: 20060165682
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include antibodies, e.g., humanized antibodies.
    Type: Application
    Filed: December 15, 2005
    Publication date: July 27, 2006
    Inventors: Guriq Basi, Jack Jacobsen
  • Humanized antibodies that recognize beta amyloid peptide
    Publication number: 20050249725
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Application
    Filed: February 27, 2004
    Publication date: November 10, 2005
    Inventors: Dale Schenk, Guriq Basi